Endothelium-Independent Hypoxic Contraction Is Prevented Specifically by Nitroglycerin via Inhibition of Akt Kinase in Porcine Coronary Artery

Stem Cells International
Huixia LiuDou Dou

Abstract

Objective. Hypoxia-induced sustained contraction of porcine coronary artery is endothelium-independent and mediated by PI3K/Akt/Rho kinase. Nitroglycerin (NTG) is a vasodilator used to treat angina pectoris and acute heart failure. The present study was to determine the role of NTG in hypoxia-induced endothelium-independent contraction and the underlying mechanism. Methods and Results. Organ chamber technique was used to measure the isometric vessel tension of isolated porcine coronary arteries. Protein levels of phosphorylated and total Akt were determined by western blot. A sustained contraction of porcine coronary arteries induced by hypoxia was significantly reduced by NTG but not by isoproterenol. This contraction was also inhibited by DETA NONOate, 8-Br-cGMP, which can be reversed by ODQ, and Rp-8-Br-PET-cGMPS. The restored contraction was blocked by LY294002. The reduction of Akt-p at Ser-473 by NTG, DETA NONOate, and 8-Br-cGMP was significantly inhibited by ODQ, PKG-I. The decrease in Akt-p level by NTG and 8-Br-cGMP was prevented by calyculin A but not by okadaic acid. Conclusions. These results demonstrated that the endothelium-independent sustained hypoxic vasoconstriction can be prevented by NTG and that the inhibit...Continue Reading

References

May 1, 1976·The American Journal of Physiology·P M Vanhoutte
Dec 1, 1991·The American Journal of Physiology·T Gräser, P M Vanhoutte
Mar 31, 1989·Biochemical and Biophysical Research Communications·H IshiharaD Uemura
Sep 1, 1989·European Heart Journal·G M GuiraudonC M Guiraudon
Feb 1, 1984·American Heart Journal·M KarmazynN S Dhalla
Aug 1, 1996·Clinical and Experimental Pharmacology & Physiology·P J PearsonP M Vanhoutte
Mar 30, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P ViardN Macrez
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Liyan MiaoJohn Zhang
Aug 24, 2002·Circulation Research·Masataka Sata, Ryozo Nagai
Jul 10, 2004·Circulation Research·Catherine Le BlancNathalie Macrez
Oct 16, 2004·The EMBO Journal·Angela GeiselhöringerJens Schlossmann
Jul 15, 2006·Trends in Cardiovascular Medicine·Gervaise LoirandPierre Pacaud
Nov 7, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Yuansheng GaoJ Usha Raj
Oct 10, 2008·The Biochemical Journal·Vincent Duronio
Nov 18, 2008·Developmental Biology·Akihiro FujinoPatricia K Donahoe
Jan 15, 2009·Journal of Cellular Physiology·Lingling ZhangShengnan Wu
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lazaros C FoukasBart Vanhaesebroeck
Nov 12, 2010·Journal of cardiology·Hiroaki Kawano, Koichi Node
Oct 11, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Calvin K Y ChanPaul M Vanhoutte
Oct 19, 2011·Circulation·Gaetano Antonio LanzaFilippo Crea
Oct 11, 2012·Stem Cells International·Sonia Martínez-HerreroAlfredo Martínez
Jun 8, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Zhengju ChenYuansheng Gao

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.